Mast Cell Chymase and Kidney Disease

Abstract

A sizable part (~2%) of the human genome encodes for proteases. They are involved in many physiological processes, such as development, reproduction and inflammation, but also play a role in pathology. Mast cells (MC) contain a variety of MC specific proteases, the expression of which may differ between various MC subtypes. Amongst these proteases, chymase represents up to 25% of the total proteins in the MC and is released from cytoplasmic granules upon activation. Once secreted, it cleaves the targets in the local tissue environment, but may also act in lymph nodes infiltrated by MC, or systemically, when reaching the circulation during an inflammatory response. MC have been recognized as important components in the development of kidney disease. Based on this observation, MC chymase has gained interest following the discovery that it contributes to the angiotensin-converting enzyme’s independent generation of angiotensin II, an important inflammatory mediator in the development of kidney disease. Hence, progress regarding its role has been made based on studies using inhibitors but also on mice deficient in MC protease 4 (mMCP-4), the functional murine counterpart of human chymase. In this review, we discuss the role and actions of chymase in kidney disease. While initially believed to contribute to pathogenesis, the accumulated data favor a more subtle view, indicating that chymase may also have beneficial actions.

Sex Differences in Arteriovenous Fistula Failure: Insights from Bioinformatics Analysis

“…Mast cells, found in nearly all vascularized tissues, are a potential source of bioactive secreted products, including cytokines and growth factors [ 62 ]. Different types of proteases release from cytoplasmic granules after mast cell activation and cleave targets in local tissue environments, but may also play a part in mast-cell-infiltrated lymph nodes or elicit pro-inflammatory reactions in the circulatory system [ 63 ]. Chymase is an important component of secretory granules of mast cells.…”

“…Mast-cell chymotrypsin can promote the production of angiotensin II, causing increased inflammation in the kidney or other tissues. Inhibition of mast-cell activation and degranulation may have a potential role in reducing inflammation and collagen deposition in AVF failure [ 63 ].…”

Construction and Analysis of Immune Infiltration-Related ceRNA Network for Kidney Stones

“…Moreover, Xi et al (2019) demonstrated that Sirtuin 3-overexpression suppressed crystal deposition through the promotion of the polarization of M2 macrophages. Mast cells have been considered as important components in kidney disease development ( Vibhushan et al, 2020 ). Summers et al (2012) demonstrated that mast cell activation and degranulation promoted renal fibrosis in mice with unilateral ureteric obstruction, while mast cell-deficient mice showed decreased collagen deposition.…”

La neurotoxine dérivée des éosinophiles (EDN) : intérêt du dosage dans les pathologies mastocytaires

“…✓ l'homéostasie tissulaire, grâce à leur capacité de croissance et de remodelage, par exemple au niveau rénal (16), osseux (17), neurologique (18), digestif (19).…”